Results 121 to 130 of about 47,725 (189)

In-silico investigations of bioactive compounds from ginger against Lassa fever virus nucleoprotein. [PDF]

Sci Rep
Eyo AE, Edet UO, Abdalla M, Bassey IU, Al-Shouli S, Mbim E, Alghamdi H, Kurdee Z, Alrukhayes M, Imalele EE, Reuben OE, Nwaokorie F, Meseko C.   +12 more
europepmc   +1 more source

Bivalent SARS-CoV-2 spike immunization with non-replicative antibiotic resistance-free DNA vaccine induces immunity to multiple virus variants. [PDF]

Sci Rep
Larraga J, Nogales-Altozano P, Gomez-Marcos L, Ruiz S, Loayza FJ, Rivera-Rodríguez A, Louloudes-Lázaro A, Carlon AB, Rodríguez-Martín D, Alonso A, Martín V, Alcolea PJ, Rojas JM, Larraga V, Sevilla N.   +14 more
europepmc   +1 more source

Viral lineage and mode of exposure modulate within-host spatial dynamics of influenza A viruses in a guinea pig model. [PDF]

J Virol
Leyson CM, Vargas-Maldonado N, Gaddy M, Raghunathan V, Ferreri LM, Sethi M, Patatanian K, Carnaccini S, Ganti K, VanInsberghe D, Lowen AC.   +10 more
europepmc   +1 more source

Vector-Induced Humoral Responses After rVSVΔG-ZEBOV-GP Immunization Identify Vaccinated Individuals and Correlate With Ebola Virus Glycoprotein Antibodies. [PDF]

J Infect Dis
Chandrasekaran P, Berry IM, Callier V, Anthony SM, Hensley K, Kuhn JH, Shaw-Saliba K, Kennedy SB, Kieh M, Browne SM, Crozier I, Davey RT, Lane HC, Hensley LE, Follmann DA.   +14 more
europepmc   +1 more source

Comparison of two nanomaterial labels for detection of SARS-CoV-2 nucleocapsid antigen to improve analytical performance of lateral flow immunoassays. [PDF]

RSC Adv
Srinivasan B, Rivera M, Caicedo C, Cárdenas WB, Finkelstein JL, Erickson D, Mehta S.   +6 more
europepmc   +1 more source

In silico drug repurposing targeting fusion and nucleoprotein of human metapneumovirus: A step toward pandemic preparedness.

Indian J Pharmacol
Rajput H, Choudhary G, Siddiqui H, Ghosh A, Prajapat M, Prakash A, Medhi B.   +6 more
europepmc   +1 more source

A renewed perspective on TCA intermediate cis-aconitate: mechanisms and therapeutic options against influenza virus. [PDF]

EMBO Mol Med
Claus C, Kovacevic I.
europepmc   +1 more source

Snapshot of an intermediate structure. [PDF]

Elife
Shinohara A.
europepmc   +1 more source

Identification and characterization of a novel inhibitor of influenza A virus that acts by blocking nucleoprotein oligomerization. [PDF]

Antimicrob Agents Chemother
Leonard VHJ, Vidales DB, Taft BR, Hesse MJ, Lee PS, Mamo M, Bussiere DE, Wolff KC, Kuhen KL, Wedel L, Growcott E, Osborne C, Octaviani CP, Huang P, Tseng C-TK, Abend JR, Wong KA, Zhong W, Tully DC, Ganem D.   +19 more
europepmc   +1 more source

In silico prediction, molecular docking and simulation of natural flavonoid apigenin and xanthoangelol E against human metapneumovirus. [PDF]

In Silico Pharmacol
Rahaman HH, Khan A, Sharif N, Ahmed W, Sharif N, Majumder R, Obregon SA, Iglesias RC, De la Torre Díez I, Dey SK.   +9 more
europepmc   +1 more source